Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pulmonx (LUNG) Revenue (2019 - 2025)

Historic Revenue for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to $21.5 million.

  • Pulmonx's Revenue rose 546.92% to $21.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $91.7 million, marking a year-over-year increase of 1558.85%. This contributed to the annual value of $83.8 million for FY2024, which is 2200.8% up from last year.
  • Per Pulmonx's latest filing, its Revenue stood at $21.5 million for Q3 2025, which was up 546.92% from $23.9 million recorded in Q2 2025.
  • Over the past 5 years, Pulmonx's Revenue peaked at $23.9 million during Q2 2025, and registered a low of $9.2 million during Q1 2021.
  • Its 5-year average for Revenue is $17.0 million, with a median of $17.2 million in 2023.
  • As far as peak fluctuations go, Pulmonx's Revenue soared by 23223.52% in 2021, and later skyrocketed by 181.74% in 2022.
  • Quarter analysis of 5 years shows Pulmonx's Revenue stood at $13.7 million in 2021, then increased by 12.53% to $15.4 million in 2022, then rose by 24.98% to $19.3 million in 2023, then increased by 23.28% to $23.8 million in 2024, then fell by 9.52% to $21.5 million in 2025.
  • Its last three reported values are $21.5 million in Q3 2025, $23.9 million for Q2 2025, and $22.5 million during Q1 2025.